approved EB-1B
Research Fellow
Cancer Immunotherapy · China · 2021-05-27
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.
Framework Evaluation
3 of 2 criteria metScholarly Articles (Met)
The petitioner authored 9 peer-reviewed articles and a book chapter in high-impact journals.
Original Research Contributions (Met)
Her research on immune checkpoints and therapeutic targets was recognized as having a significant impact on the field and U.S. healthcare.
Judging the Work of Others (Met)
The petitioner completed 50 peer review assignments, demonstrating her standing in the field.
Why This Petition Was Approved
The petition was approved based on 9 peer-reviewed articles and 1 book chapter which garnered 108 citations. Additionally, the petitioner's record of judging the work of peers 50 times and her 15 years of research experience satisfied the EB-1B criteria for international recognition.
Evidence
Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Judging Experience
Original Contributions
Evidence Submitted
- 9 peer-reviewed scientific articles
- 1 book chapter
- 108 citations from well-reputed researchers
- 50 peer review assignments
- Doctor of Medicine in clinical medicine
- 15 years of research experience in cancer immunotherapy
Similar Cases
Scientist
Biotechnology · China
WeGreened EB-1B approved
10 days 2026-01-30
The case was approved based on the petitioner's record of 8 peer-reviewed journal articles and 105 citations, demonstrating international recognition. Additionally, the petitioner's participation in over 30 peer reviews for high-impact journals and receipt of major funding from NIGMS and NIAID satisfied the EB-1B criteria.
Assistant Professor
Research and Development · Taiwan
WeGreened EB-1B approved
New Jersey 6 days 2026-01-29
The approval was based on the petitioner's 25 peer-reviewed journal articles, 2 conference articles, and 36 abstracts, which garnered 97 citations. Additionally, the petitioner demonstrated expertise through 17 peer reviews and documented original contributions to socioenvironmental factors of healthcare. These metrics satisfied the EB-1B requirements for international recognition and original research contributions.
Statistician
Biotechnology · China
WeGreened EB-1B approved
Maryland 21 days 2026-01-28
The case was approved based on the petitioner's international recognition as an outstanding researcher, supported by 8 peer-reviewed journal articles and 435 citations. The petitioner also demonstrated professional standing through 17 manuscript reviews for journals in the field. The research's practical application in small electronics and its support from the National Institute of Food and Agriculture further validated its significance.
Assistant Professor
Social Sciences · Brazil
WeGreened EB-1B approved
Minnesota 13 days 2026-01-15
The approval was based on a strong record of 11 journal articles and 3 book chapters, coupled with 74 citations and an h-index of 5. The petitioner demonstrated international recognition through 5 peer reviews for respected journals and leadership roles in a major professional association. The case satisfied EB-1B criteria by proving the petitioner's work is method-driven, verifiable, and applied by others in the field.
Frequently Asked Questions
A approved EB-1B (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2021-05-27.
Browse all casesAt a Glance
Outcome approved
Processing 9 days
Criteria Met 3 / 2
Evidence Types 5
EB-1B Case Data
Scraped Case Data
Total Cases 77
Success Rate 98.7%
Sustained 76
Dismissed 1
Related Pages
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist